Robert Schupp - Market Access Consultant for Germany

🚀 FRATCH GPT 2.0 - Find freelancers with a single prompt. Now including price benchmarking.

Recommended expert

Tutzing, Germany

Check rate

Experience

Sep 2024 - Dec 2025

1 year 4 months

External Consultant Market Access Germany

Paion Pharma GmbH

Secured market access for 3 ICU products and supported a relaunch
Led projects and provided strategic advice for the preparation and submission of the AMNOG benefit assessment for Byfavo® in sedation
Trained and supported KAMs on regional market access

Jun 2023 - Dec 2023

7 months

External Consultant Market Access Germany

CSL Behring

Led the preparation and provided strategic advice for the AMNOG process, including price and reimbursement for the orphan drug Garadacimab in HAE
Collaborated closely with global and regional market access teams to ensure alignment with European and corporate strategies
Monitored health policy developments, HTA trends, and reimbursement landscapes to inform local access strategies

Apr 2021 - Aug 2023

2 years 5 months

France

General Manager DACH

Gensight Biologics

Built trusted relationships with key stakeholders in Germany and Austria, especially health authorities, KOLs, and patient advocacy groups
Expedited early access for the gene therapy Lumevoq® in ophthalmology and drove pre-launch campaigns for this ATMP
Translated clinical and economic evidence into compelling value arguments tailored to the German healthcare system
Built the network of gene therapy centers, addressing stringent quality control requirements

May 2015 - Jan 2021

5 years 9 months

Germany

General Manager DACH

Santhera

Built and led a cross-functional team and regional affiliate to commercialize an ultra-orphan drug for mitochondrial and neuromuscular diseases
Successfully launched and secured market access (AMNOG and price negotiations with GKV-SV) for the lead compound Raxone® in Leber's hereditary optic neuropathy (LHON)
Achieved consistent growth, peaking at 39% year-over-year growth in 2019
Established the first patient registry in LHON
Timely achieved launch readiness in initial countries for entering the Duchenne muscular dystrophy market with the new brand Puldysa®

Jan 2014 - Oct 2014

10 months

United States

General Manager DACH

Synageva BioPharma

Focused on all aspects of building an ultra-rare disease franchise, including establishing a strong disease awareness campaign for LAL deficiency and setting up regional infrastructure to support market access and launch
Extensively engaged with academia, physicians, and patient advocacy groups to drive testing and identification of the patient population

Nov 2011 - Nov 2013

2 years 1 month

Switzerland

Executive Director Biomarker & Diagnostics Hematology/Oncology

Celgene International

Developed and implemented an overall biomarker and diagnostic strategy within the global cross-functional team and external stakeholders
As a member of the global brand team, created EU market entry and brand plan to prepare launch of Imnovid® in myelofibrosis
Contributed to the global business development team and evaluated new business opportunities in the EU (new NCEs and/or co-operations)
Built a solid ecosystem with external stakeholders through speaker participation at industry associations and biomarker congresses

Jan 2009 - Mar 2012

3 years 3 months

Germany

General Manager

Celgene GmbH

Led a dynamically growing franchise of 300 M USD and 140 employees; managed two business units (hematology and oncology), finance, HR, external communications, market access & reimbursement, medical department
Member of the EU management committee and several task forces, including EMEA central warehouse project and pomalidomide prelaunch team
Developed and implemented a strategic plan to leverage the orphan drug portfolio and achieved exceptional evaluation within AMNOG
Led the healthcare-economics task force of BioDeutschland and executed several key governmental affairs initiatives in rare diseases
Surpassed revenue and margin goals, generated double-digit growth year over year and secured fastest growing affiliate status in the EU5
Built up a new oncology business unit and successfully re-launched Abraxane® in the highly competitive breast cancer market

Mar 2006 - Dec 2008

2 years 10 months

Germany

Director Sales & Marketing

Celgene GmbH

Built and led high-performance sales, marketing and market access organizations from the ground up and established impactful operations
Developed and executed CRM strategy, gaining trust of key opinion leaders, payers and patient advocacy groups towards a start-up company
Established the first NPP for a contergan derivative
Successfully launched Revlimid® in a competitive market, achieving market leadership within two years
Launched Thalidomide® and Vidaza® drugs successfully
Led smooth post M&A integration of Pharmion business and staff

May 2004 - Mar 2006

1 year 11 months

Manager Distributor Operations in 9 EU countries

Abbott International / Hospira BV

Led and project-managed the spin-off of Abbott’s hospital business, overseeing a diverse portfolio of critical care and i.v. generic products
Negotiated with distributors and affiliate Abbott senior leadership
Established distributor network in nine countries, negotiated contracts with selected partners, established metrics and monitored progress versus goals
Achieved successful spin-off by the SEC deadline
Rolled out autonomous regional operations on time

Dec 2003 - May 2004

6 months

Germany

General Manager

Wolters Kluwer Health

Spearheaded organizational transformation into a locally managed subsidiary and reengineered affiliate governance structure
Created short- and long-term business growth plans
Achieved significant sales growth: +26% versus plan and +5% versus prior year

Mar 2003 - Sep 2003

7 months

General Manager ad interim

Foundation for Living of the Elderly

Developed cost center system and balance sheet for 2002
Prepared expense plan and conducted the annual lodgers meeting

Dec 1998 - Sep 2003

4 years 10 months

Germany

Business Unit Manager Oncology & Hematology

Schering-Plough

Led two hematology and oncology business units, marketing a portfolio of five oncology drugs and overseeing a team of up to 60; managed P&L for €70 M with double-digit growth rates
Led major field force restructuring and organizational change
Implemented a program to compete with parallel imports including sales force, service level, CRM project and targeted rebating
Worked within the corporate oncology task force and contributed to the SBU portfolio and generic defense strategy
Developed and implemented short- and long-range strategic plans and annual business and medical affairs plans
Successfully launched two new drugs (Temodal®, Caelyx®) and established a co-promotion partnership with Grünenthal on a buprenorphine patch (Transtec®)
Secured endorsement of high-dose interferon (Intron® A) therapy by the German Dermatology Association
Initiated high-profile multi-institutional trials, e.g. CML-4 study

Jul 1993 - Feb 1997

3 years 8 months

Germany

European Product Manager Immunoselection

BAXTER Healthcare

Developed and implemented annual strategic and brand plans
Managed research and clinical projects, including design and data collection
Organized international symposia and conducted customer training programs in-house and on-site
Launched several line extensions of ISOLEX®

Jan 1993 - Dec 1998

6 years

Germany

BU-Manager Immunotherapy Europe

BAXTER Healthcare

Directed sales, budget and P&L responsibility for several medical device products for clinical use of bone marrow or peripheral blood
Licensed, acquired and launched a diagnostic kit in breast cancer
Served as commercial leader for the EMEA sales team; established a cross-functional team to serve transplant units, blood banks and centers of excellence
Tripled sales in five years, achieved market leadership in the selection market and reached divisional break-even
Managed smooth transition of immunoselection business to a joint venture partner, Nexell Therapeutics, USA

Nov 1991 - Jun 1993

1 year 8 months

Germany

Sales Representative Hematology

AMGEN

Generated €1 M in annual Neupogen® sales and ranked #2 of 10
Contributed to the first development of PBSCT in myeloma at a center of excellence

Industry experience

See where this freelancer has spent most of their professional time.

Experienced in Pharmaceutical, Biotechnology, and Healthcare.

Pharmaceutical

Biotechnology

Healthcare

Business area experience

See which departments and functions this freelancer has contributed to most.

Experienced in Marketing, Sales, Strategy, Product Development, Operations, and Project Management.

Marketing

Sales

Strategy

Product Development

Operations

Project Management

Summary

30+ years’ industry experience with extensive experience in rare diseases/ orphan drugs
At Celgene Germany, set up and built out their Market Access department (in response to new AMNOG legislation) and worked across their portfolio in hematology and oncology.
At Santhera, led the DACH Market Access workstream for the rare disease portfolio; launched RAXONE (orphan ophthalmology asset) in LHON, achieved launch readiness for PULDYSA in DMD.
At GenSight, ensure launch readiness, with a primary focus on market access of their ultra-orphan gene therapy product LUMEVOQ, esp. regarding early payer engagement, contracting, national HTA submissions and new regulations for ATMPs
Member of the DFGMA (German Society for Market Access)
Motivation: I want to leverage my broad and deep expertise in market access and provide ad-hoc support and on-demand interim management. I have a passion for working with people to help launch innovative products in areas of high unmet need

Skills

Teaching Experience: Trainer At The University Of Cologne And At A College

Languages

German

Native

English

Advanced

French

Elementary

Education

Oct 2013 - Jun 2014

European Business School (EBS)

Postgraduate study · Market Access Management · Oestrich-Winkel, Germany · Grade 1.4

Oct 2001 - Jun 2003

University of Cologne

MBA - Postgraduate study · Business Administration · Cologne, Germany · Grade: Good

Oct 1987 - Jun 1991

Technical University of Munich

Ph.D. · Biochemistry · Munich, Germany · summa cum laude

...and 2 more

Certifications & licenses

First State Examination for Secondary Level II Teaching Certification

State Examination Office for First State Examinations for School Teaching Degrees

Professional Part of the Non-Commissioned Officer Examination

Academy of Medical and Health Services of the German Armed Forces

ATN 0380

Medical Service Examination

Statistics

Experience

Total positions 15

Experience in Pharmaceutical 29.5 y

Avg length 2 y 6 m

Longest experience 5 y 11 m

Global experience

Countries worked in 4 (Germany, France, United States, Switzerland)

Primary country Germany

Expertise

Recent roles External Consultant Market Access Germany, General Manager DACH, Executive Director Biomarker & Diagnostics Hematology/Oncology

Main industries Pharmaceutical, Biotechnology, Healthcare

Main business areas Marketing, Sales, Strategy

Qualifications

Highest degree Doctorate

Certifications earned 4

Profile

Member since

March 2026

Need a freelancer? Find your match in seconds.

Try FRATCH GPT

Frequently asked questions

Have questions? Find more information here.

Robert is based in Tutzing, Germany.

Robert speaks the following languages: German (Native), English (Advanced), French (Elementary).

Robert has at least 32 years of experience. During this time, Robert has worked in at least 11 different roles and for 13 different companies. The average length of individual experience is 2 years and 2 months. Note that Robert may not have shared all experience and actually has more experience.

Based on recent experience, Robert would be well-suited for roles such as: External Consultant Market Access Germany, General Manager DACH, Executive Director Biomarker & Diagnostics Hematology/Oncology.

Robert's most recent position is External Consultant Market Access Germany at Paion Pharma GmbH.

In recent years, Robert has worked for Paion Pharma GmbH, CSL Behring, and Gensight Biologics.

Robert is most experienced in industries like Pharmaceutical, Biotechnology, and Healthcare.

Robert is most experienced in business areas like Marketing, Sales, and Strategy. Robert also has some experience in Product Development, Operations, and Project Management.

Robert has recently worked in industries like Biotechnology and Pharmaceutical.

Robert has recently worked in business areas like Marketing, Quality Assurance, and Strategy.

Robert holds a Doctorate in Biochemistry from Technical University of Munich, a Master in Business Administration from University of Cologne and a Master in Biology, Chemistry from University of Cologne.

Robert has 4 certificates. Among them, these include: First State Examination for Secondary Level II Teaching Certification, Professional Part of the Non-Commissioned Officer Examination, and ATN 0380.

The availability of Robert needs to be confirmed.

Daily rate distribution

0 1 2 3 4

<€720 €720-800 €800-880 €880-960 €960-1040 €1040-1120 €1120+

The rates shown represent the typical market range for freelancers in this position based on recent contracts on our platform.

Average rates for similar positions

Rates are based on recent contracts and do not include FRATCH margin.

1000

750

500

250

Daily rate avg. 891 €

The average daily rate is the mean of all daily rates from recent contracts of comparable freelancers on our platform.

1000

750

500

250

Median rate 864 €

The median daily rate is the middle value of all daily rates — half of comparable freelancers charge less, half charge more. Unlike the average, it is barely affected by outliers.

Calculated based on our freelancers’ daily rates as of 25 Aug 2026. Actual rates may vary depending on seniority level, experience, skill specialization, project complexity, and engagement length.